The high-throughput screening platform implemented for drug discovery is driven by the therapeutic areas of interest. Therefore the speed and information derived is governed by these areas. Multiple technologies are needed to exploit this and it is also important to show reactivity to new advances in technology. In contrast with a drive over the last few years towards higher throughput and speed, higher information content will be instrumental in driving lead discovery in the future.

Keywords:
high-throughput screening, ion channel, nuclear receptor, FRET, fluorescence resonance energy transfer, VIPR, voltage/ion probe reader, HTS, high-throughput screening
This content is only available as a PDF.
© 2002 Biochemical Society
2002
You do not currently have access to this content.